SCYNEXIS
SCYX
#10674
Rank
A$35.38 M
Marketcap
A$3.56
Share price
-9.02%
Change (1 day)
291.08%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): A-$7.69

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is A-$7.80. In 2025 the company made an earnings per share (EPS) of A-$2.04 an increase over its 2024 EPS that were of A-$5.28.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$7.69276.86%
2025A-$2.04-61.36%
2024A-$5.28-131.43%
2023A$16.80-195.24%
2022A-$17.6417.6%
2021A-$15.00-75.73%
2020A-$61.80-46.24%
2019A-$114.97242.14%
2018A-$33.60-70.21%
2017A-$112.81-40.51%
2016A-$189.61-41.04%
2015A-$321.62157.69%
2014A-$124.81-96.49%
2013A-$3,553307.85%
2012A-$871.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
A-$19.32 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
A$2.72-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
A-$9.50 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
A-$1.49-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA